“The Money Machine:” Keith Schaefer’s “Premiere Growth+Dividend Investment”

I haven’t written about Keith Schaefer in a while, so with oil prices dropping and scaring all the oil investors I thought we’d take a gander at the stock he’s teasing as “one of the safest, long-term growth investments I have ever come across in my investing career.” The pitch is that this company is […]

“The End of Rust” — What’s Nick Hodge’s “Oscar of Innovation” corrosion-fighting stock?

This teaser pitch started running, and we covered it, in mid-September — this article originally ran on September 18. It has not been updated or revised in the six weeks since then, but the ad is still in heavy enough rotation that many people are asking about it again, so we’re re-posting it for you. […]

“It’s going to be the ‘Apple’ of cancer therapy in the next 20 years.”

Immunotherapy for cancer has been in the news quite a bit in recent years, with several drugs making an impact on the worst cancers and giving some real hope for future advancement — not a small thing for a basic medical strategy that’s been tested and tweaked for 125 years now by folks following in […]

Ebola: To Parse, Perchance to Parlay

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He chooses his own topics, and his words and opinions are his own.] Careful analysis of Ebola sequences in infected Africans confirms this: the entire present Ebola outbreak emerged as a consequence of one boy in Meliandoua, in eastern Guinea, eating a […]

“Triple-Digit Profits from the Diabetic ‘Patch’ Company Going to $1 Billion.”

Today the pitch that’s been catching my eye is from Mitchell Clark for his Biotech Breakthrough Stock Report — we haven’t covered this newsletter before, but we have certainly covered teaser spiels from Mitchell Clark’s wide variety of Lombardi-published newsletters in the past (before he was a biotech expert this week, he was a bible […]

Unraveled: “Warren Buffett’s Worst Nightmare” pitch from the Motley Fool

We’ve had many questions from readers about this teaser spiel from the Motley Fool Stock Advisor letter, so we’re republishing an excerpt of the Friday File in which we solved that teaser. What follows originally appeared as a part of the Friday File on May 9, it has not been updated or revised — the […]

“The Scientists Who Really Might Find a Cure for Cancer,” plus some thoughts on seismic, hospitals and hedge funds

I’ve got a few thoughts for you on some companies I follow and own, and a little follow-up on last week’s chatter about hedge funds, but first I thought you’d like a quick teaser solution for your Friday File fun… The pitch is for Stephen Petranek’s Breakthrough Technology Alert – there’s been some discussion recently […]

What’s the Motley Fool’s “Holy Grail investment into ‘Oil Boom 2.0?’”

The carnage in energy and oil services stocks over the last six months or so is causing a lot of contrarian investors to sit up and take notice — the combination of lower perceived demand (because of efficiency, slower growth in China, and the recession in Europe) and increased supply (because of the huge shale […]

“The Real Secret Behind Apple’s Biggest Success”

Ian Wyatt is pitching a stock that he says is going to surge on the demand for more wireless data that comes with each new iteration of the iPhone or Samsung Galaxy… and I didn’t look at this ad for a few days, because it sounded really familiar. Wyatt’s copywriters love the Apple iPhone connection […]

Keith Kohl and the $1 “Petroplex” Stock

This article originally appeared on August 14, neither the article nor the ad I cover here have been updated or changed, but the ad is rolling again and generating questions from readers so we’re lifting it to the top of the page for you. —-from 8/14/14—– I didn’t look at this pitch right away, since […]